MC 2133 Glycylalendronic acid, sodium salt, [alendronate-4-14C]- |
|
| HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 100 μCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | 10 μCi (370 kBq) $1240 |
| NextGen V-Vial | 50 μCi (1.85 MBq) $3970 |
M.W. 328.13
 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2166 N-t-BOC-Glycylalendronic acid, sodium salt, [alendronate-4-14C]- |
|
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 100 �Ci/ml | |
| > 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 406.3 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |